Percentage of adult patients aged 25 and older with atrial fibrillation and major stroke risk factors who are on anticoagulation therapy.
Measure Specs
General Information
Numerator
Patients with evidence of anticoagulation therapy.
Denominator
All patients with Atrial Fibrillation and one of the following:
1. Age greater than or equal to 25 with prior stroke, mitral stenosis or mitral valve replacement
2. Age greater than or equal to 75 and 1 of the following: diabetes, hypertension or CHF
3. Age less than 75 and 2 of the following: diabetes, hypertension or CHF
Exclusions
Contraindications to warfarin, including:
• Esophageal varices with bleed
• Aortic dissection
• Intracerebral hemorrhage
• Blood transfusion(RBC or platelets)
• Severe brain injury
• Dementia
• Alcohol use/abuse
• Falls
• Fracture
• Hemorrhage contraindications and procedures
• Adverse effects fromcoumadin
• Abnormal gait/incoordination
• Neuro and eye surgery
• Gastritis with Current fill of Proton pump inhibitors
• Thrombocytopenia
• Hematocrit lab value < 25
• Pregnancy
• Patient or provider feedback indicating patient has allergy, intolerance, or contraindication to the drug anytime in the past
• General exclusions:
Terminal illness anytime in the past
hospice in the past 12 months
Public Comments